• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Earnings Scheduled For November 3, 2023

    11/3/23 7:12:01 AM ET
    $ACRE
    $AMCX
    $ARQT
    $ASIX
    Real Estate Investment Trusts
    Real Estate
    Cable & Other Pay Television Services
    Telecommunications
    Get the next $ACRE alert in real time by email

    Companies Reporting Before The Bell

    • Arcutis Biotherapeutics (NASDAQ:ARQT) is expected to report quarterly loss at $0.86 per share on revenue of $32.83 million.

    • Dominion Energy (NYSE:D) is expected to report quarterly earnings at $0.77 per share on revenue of $4.38 billion.

    • Atmus Filtration Techs (NYSE:ATMU) is estimated to report quarterly earnings at $0.45 per share on revenue of $390.96 million.

    • Lovesac (NASDAQ:LOVE) is estimated to report quarterly loss at $0.13 per share on revenue of $150.66 million.

    • Enbridge (NYSE:ENB) is likely to report quarterly earnings at $0.44 per share on revenue of $8.25 billion.

    • Oncolytics Biotech (NASDAQ:ONCY) is likely to report earnings for its third quarter.

    • Brookfield Renewable (NYSE:BEP) is estimated to report quarterly earnings at $0.04 per share on revenue of $987.00 million.

    • TELUS (NYSE:TU) is projected to report quarterly earnings at $0.24 per share on revenue of $5.08 billion.

    • TELUS Intl (NYSE:TIXT) is projected to report quarterly earnings at $0.21 per share on revenue of $657.82 million.

    • Bloomin Brands (NASDAQ:BLMN) is likely to report quarterly earnings at $0.42 per share on revenue of $1.09 billion.

    • Restaurant Brands Intl (NYSE:QSR) is expected to report quarterly earnings at $0.86 per share on revenue of $1.88 billion.

    • Cinemark Hldgs (NYSE:CNK) is likely to report quarterly earnings at $0.42 per share on revenue of $834.58 million.

    • Privia Health Gr (NASDAQ:PRVA) is estimated to report quarterly earnings at $0.05 per share on revenue of $702.46 million.

    • Icahn Enterprises (NASDAQ:IEP) is likely to report quarterly earnings at $0.34 per share on revenue of $2.71 billion.

    • Editas Medicine (NASDAQ:EDIT) is expected to report quarterly loss at $0.57 per share on revenue of $3.42 million.

    • Owens & Minor (NYSE:OMI) is likely to report quarterly earnings at $0.35 per share on revenue of $2.58 billion.

    • iRadimed (NASDAQ:IRMD) is likely to report quarterly earnings at $0.36 per share on revenue of $16.17 million.

    • Moog Inc. Class A Common Stock (NYSE:MOG) is projected to report quarterly earnings at $1.71 per share on revenue of $806.33 million.

    • Lazydays Hldgs (NASDAQ:LAZY) is estimated to report quarterly earnings at $0.10 per share on revenue of $307.87 million.

    • Healthcare Realty Trust (NYSE:HR) is expected to report earnings for its third quarter.

    • US Silica Holdings (NYSE:SLCA) is expected to report quarterly earnings at $0.41 per share on revenue of $380.20 million.

    • Brookfield Bus Partners (NYSE:BBU) is expected to report earnings for its third quarter.

    • Gartner (NYSE:IT) is projected to report quarterly earnings at $1.96 per share on revenue of $1.39 billion.

    • Plains GP Holdings (NASDAQ:PAGP) is estimated to report quarterly earnings at $0.27 per share on revenue of $12.56 billion.

    • Plains All American (NASDAQ:PAA) is likely to report quarterly earnings at $0.26 per share on revenue of $14.43 billion.

    • Sempra (NYSE:SRE) is projected to report quarterly earnings at $1.00 per share on revenue of $3.68 billion.

    • American Axle & Mfg Hldgs (NYSE:AXL) is estimated to report quarterly earnings at $0.02 per share on revenue of $1.50 billion.

    • Cboe Global Markets (BATS:CBOE) is projected to report quarterly earnings at $1.86 per share on revenue of $479.89 million.

    • Fluor (NYSE:FLR) is projected to report quarterly earnings at $0.56 per share on revenue of $3.89 billion.

    • Magna International (NYSE:MGA) is estimated to report quarterly earnings at $1.34 per share on revenue of $10.33 billion.

    • E W Scripps (NASDAQ:SSP) is likely to report quarterly loss at $0.22 per share on revenue of $565.97 million.

    • Koppers Hldgs (NYSE:KOP) is likely to report quarterly earnings at $1.26 per share on revenue of $559.00 million.

    • Telephone and Data (NYSE:TDS) is likely to report quarterly loss at $0.11 per share on revenue of $1.28 billion.

    • United States Cellular (NYSE:USM) is estimated to report quarterly earnings at $0.05 per share on revenue of $1.00 billion.

    • W.P. Carey (NYSE:WPC) is likely to report quarterly earnings at $0.63 per share on revenue of $450.17 million.

    • GlycoMimetics (NASDAQ:GLYC) is expected to report earnings for its third quarter.

    • Rapid Micro Biosystems (NASDAQ:RPID) is estimated to report quarterly loss at $0.31 per share on revenue of $5.55 million.

    • Shenandoah (NASDAQ:SHEN) is likely to report quarterly loss at $0.01 per share on revenue of $71.18 million.

    • AMC Networks (NASDAQ:AMCX) is expected to report quarterly earnings at $1.28 per share on revenue of $657.80 million.

    • inTest (AMEX:INTT) is expected to report quarterly earnings at $0.25 per share on revenue of $32.65 million.

    • Proto Labs (NYSE:PRLB) is projected to report quarterly earnings at $0.30 per share on revenue of $122.61 million.

    • FuboTV (NYSE:FUBO) is expected to report quarterly loss at $0.32 per share on revenue of $286.18 million.

    • Gates Industrial Corp (NYSE:GTES) is expected to report quarterly earnings at $0.31 per share on revenue of $877.78 million.

    • Cardinal Health (NYSE:CAH) is likely to report quarterly earnings at $1.41 per share on revenue of $54.76 billion.

    • AdvanSix (NYSE:ASIX) is projected to report quarterly loss at $0.03 per share on revenue of $367.90 million.

    • Ares Comml Real Est (NYSE:ACRE) is estimated to report quarterly earnings at $0.21 per share on revenue of $25.32 million.

    • Corebridge Financial (NYSE:CRBG) is expected to report quarterly earnings at $1.04 per share on revenue of $5.07 billion.

    • Fulgent Genetics (NASDAQ:FLGT) is expected to report quarterly loss at $0.33 per share on revenue of $63.41 million.

    • Natural Resources (NYSE:NRP) is projected to report earnings for its third quarter.

    • Marcus & Millichap (NYSE:MMI) is expected to report quarterly loss at $0.26 per share on revenue of $164.80 million.

    • Northwest Natural Hldg (NYSE:NWN) is likely to report quarterly loss at $0.67 per share on revenue of $134.78 million.

    • Brookfield Renewable (NYSE:BEPC) is expected to report earnings for its third quarter.

    • Interface (NASDAQ:TILE) is expected to report quarterly earnings at $0.26 per share on revenue of $324.75 million.

    • Atlanta Braves Holdings (NASDAQ:BATRK) is projected to report quarterly earnings at $0.21 per share on revenue of $268.70 million.

    • Atlanta Braves Holdings (NASDAQ:BATRA) is expected to report quarterly earnings at $0.32 per share on revenue of $268.50 million.

    • Qurate Retail (NASDAQ:QRTEB) is estimated to report earnings for its third quarter.

    • Qurate Retail (NASDAQ:QRTEA) is estimated to report quarterly earnings at $0.04 per share on revenue of $2.54 billion.

    • Liberty Formula One Group (NASDAQ:FWONK) is projected to report quarterly earnings at $0.20 per share on revenue of $900.58 million.

    • Liberty Formula One Group (NASDAQ:FWONA) is expected to report quarterly earnings at $0.26 per share on revenue of $895.00 million.

    • Liberty SiriusXM Gr (NASDAQ:LSXMK) is projected to report quarterly earnings at $0.88 per share on revenue of $2.30 billion.

    • Liberty SiriusXM Gr (NASDAQ:LSXMA) is expected to report quarterly earnings at $0.85 per share on revenue of $2.30 billion.

    • Liberty Broadband (NASDAQ:LBRDK) is estimated to report quarterly earnings at $2.43 per share on revenue of $257.00 million.

    • Liberty Broadband (NASDAQ:LBRDA) is expected to report quarterly earnings at $2.18 per share on revenue of $252.20 million.

    • GrafTech International (NYSE:EAF) is projected to report quarterly loss at $0.03 per share on revenue of $180.00 million.

    • Church & Dwight Co (NYSE:CHD) is projected to report quarterly earnings at $0.68 per share on revenue of $1.43 billion.

    • MISTRAS Group (NYSE:MG) is projected to report quarterly earnings at $1.80 per share on revenue of $14.31 billion.

    • Brookfield Business (NYSE:BBUC) is estimated to report earnings for its third quarter.

    Companies Reporting After The Bell

    • Eversource Energy (NYSE:ES) is projected to report quarterly earnings at $0.99 per share on revenue of $3.29 billion.

    • Trinseo (NYSE:TSE) is likely to report quarterly loss at $0.96 per share on revenue of $973.00 million.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $ACRE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACRE
    $AMCX
    $ARQT
    $ASIX

    CompanyDatePrice TargetRatingAnalyst
    Brookfield Business Partners L.P. Limited Partnership Units
    $BBU
    2/27/2026$44.00Sector Outperform
    CIBC
    Liberty Media Corporation
    $FWONK
    2/27/2026$95.00Underweight → Equal Weight
    Wells Fargo
    Enbridge Inc
    $ENB
    2/17/2026Buy → Hold
    TD Securities
    Enbridge Inc
    $ENB
    2/17/2026Buy → Hold
    Jefferies
    Eversource Energy (D/B/A)
    $ES
    2/17/2026$78.00Equal Weight → Overweight
    Wells Fargo
    Church & Dwight Company Inc.
    $CHD
    2/13/2026$91.00Sell → Neutral
    Rothschild & Co Redburn
    FuboTV Inc.
    $FUBO
    2/5/2026$3.00Neutral → Buy
    Seaport Research Partners
    Church & Dwight Company Inc.
    $CHD
    2/2/2026$100.00Underweight → Neutral
    Analyst
    More analyst ratings

    $ACRE
    $AMCX
    $ARQT
    $ASIX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Arcutis Management to Present at TD Cowen's 46th Annual Health Care Conference

    WESTLAKE VILLAGE, Calif., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis management will present at the TD Cowen 46th Annual Health Care Conference, taking place March 2-4, 2026, in Boston. Details for the Company's participation are as follows:     Fireside Chat: Monday, March 2, 2026 at 1:50 p.m. ET The webcast for this conference may be accessed via the "Events" section of the Company's website. A replay of the webcast will be available on the Arcutis website for 180 days following the conference. About ArcutisAr

    2/27/26 4:00:00 PM ET
    $ARQT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Brookfield Renewable Completes Annual Filings

    BROOKFIELD, News, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Brookfield Renewable (NYSE:BEP, BEPC, TSX:BEP, BEPC)) announced today the filing of its 2025 annual reports, including audited financial statements for the year ended December 31, 2025, on Forms 20-F with the SEC on EDGAR as well as with Canadian securities regulatory authorities on SEDAR+. These documents are available at bep.brookfield.com (or for Brookfield Renewable Corporation, at bep.brookfield.com/bepc), on the SEC's website at www.sec.gov and on SEDAR+'s website at www.sedarplus.ca. Hard copies will be provided to unitholders and shareholders free of charge upon request. Brookfield Renewable Brookfield Renewable operates one of

    2/27/26 9:30:48 AM ET
    $BEP
    $BEPC
    Electric Utilities: Central
    Utilities

    Fulgent Reports Fourth Quarter and Full Year 2025 Financial Results

    Revenue of $83.3 million, growing 9% year-over-year GAAP gross profit of $32.6 million, or GAAP gross margin of 39.1%; Non-GAAP gross profit of $34.2 million, or Non-GAAP gross margin of 41.0% GAAP loss of $23.4 million, or ($0.76) per share; Non-GAAP income of $5.2 million, or $0.16 per share Ended the year with $705.5 million of cash, cash equivalents, restricted cash, and investments in marketable securities, excluding an anticipated tax refund of approximately $106.3 million Fulgent Genetics, Inc. (NASDAQ:FLGT) ("Fulgent," or the "Company"), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announce

    2/27/26 7:00:00 AM ET
    $FLGT
    Medical Specialities
    Health Care

    $ACRE
    $AMCX
    $ARQT
    $ASIX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for ZORYVE issued to ARCUTIS BIOTHERAPEUTICS INC

    Submission status for ARCUTIS BIOTHERAPEUTICS INC's drug ZORYVE (ORIG-1) with active ingredient ROFLUMILAST has changed to 'Approval' on 12/15/2023. Application Category: NDA, Application Number: 217242, Application Classification: Type 3 - New Dosage Form

    12/19/23 3:40:08 PM ET
    $ARQT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for ZORYVE issued to ARCUTIS BIOTHERAPEUTICS INC

    Submission status for ARCUTIS BIOTHERAPEUTICS INC's drug ZORYVE (ORIG-1) with active ingredient ROFLUMILAST has changed to 'Approval' on 12/15/2023. Application Category: NDA, Application Number: 217242, Application Classification: Type 3 - New Dosage Form and Type 4 - New Combination

    12/15/23 5:01:31 PM ET
    $ARQT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACRE
    $AMCX
    $ARQT
    $ASIX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    CIBC initiated coverage on Brookfield Business Partners with a new price target

    CIBC initiated coverage of Brookfield Business Partners with a rating of Sector Outperform and set a new price target of $44.00

    2/27/26 9:41:26 AM ET
    $BBU
    Engineering & Construction
    Consumer Discretionary

    Formula One Group C upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded Formula One Group C from Underweight to Equal Weight and set a new price target of $95.00

    2/27/26 8:21:46 AM ET
    $FWONK
    Broadcasting
    Industrials

    Enbridge downgraded by TD Securities

    TD Securities downgraded Enbridge from Buy to Hold

    2/17/26 8:44:18 AM ET
    $ENB
    Natural Gas Distribution
    Energy

    $ACRE
    $AMCX
    $ARQT
    $ASIX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Malone John C bought $630,344 worth of Series B Common Stock (10,868 units at $58.00) and sold $630,302 worth of Series C Common Stock (14,614 units at $43.13), increasing direct ownership by 72,468% to 2,662,534 units (SEC Form 4)

    4 - Atlanta Braves Holdings, Inc. (0001958140) (Issuer)

    2/27/26 4:11:45 PM ET
    $BATRK
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Director Pisano Wayne bought $25,338 worth of shares (30,000 units at $0.84), increasing direct ownership by 6% to 492,414 units (SEC Form 4)

    4 - ONCOLYTICS BIOTECH INC (0001129928) (Issuer)

    2/13/26 7:00:29 AM ET
    $ONCY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Kelly Jared bought $29,521 worth of shares (35,100 units at $0.84), increasing direct ownership by 47% to 109,000 units (SEC Form 4)

    4 - ONCOLYTICS BIOTECH INC (0001129928) (Issuer)

    2/13/26 7:00:32 AM ET
    $ONCY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACRE
    $AMCX
    $ARQT
    $ASIX
    SEC Filings

    View All

    SEC Form 10-K filed by Natural Resource Partners LP Limited Partnership

    10-K - NATURAL RESOURCE PARTNERS LP (0001171486) (Filer)

    2/27/26 5:29:21 PM ET
    $NRP
    Coal Mining
    Energy

    SEC Form 10-K filed by Plains Group Holdings, L.P.

    10-K - PLAINS GP HOLDINGS LP (0001581990) (Filer)

    2/27/26 5:05:39 PM ET
    $PAGP
    Natural Gas Distribution
    Energy

    SEC Form 10-K filed by Plains All American Pipeline L.P.

    10-K - PLAINS ALL AMERICAN PIPELINE LP (0001070423) (Filer)

    2/27/26 5:02:07 PM ET
    $PAA
    Natural Gas Distribution
    Energy

    $ACRE
    $AMCX
    $ARQT
    $ASIX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President, Popeyes-US & Canada Perdue Peter was granted 721 shares, increasing direct ownership by 2% to 43,627 units (SEC Form 4)

    4 - Restaurant Brands International Inc. (0001618756) (Issuer)

    2/27/26 5:34:37 PM ET
    $QSR
    Restaurants
    Consumer Discretionary

    Chief Corporate Officer Fulton Duncan was granted 1,540 shares, increasing direct ownership by 3% to 51,217 units (SEC Form 4)

    4 - Restaurant Brands International Inc. (0001618756) (Issuer)

    2/27/26 5:34:23 PM ET
    $QSR
    Restaurants
    Consumer Discretionary

    Chief Financial Officer Siddiqui Sami A. was granted 3,843 shares, increasing direct ownership by 12% to 35,766 units (SEC Form 4)

    4 - Restaurant Brands International Inc. (0001618756) (Issuer)

    2/27/26 5:34:31 PM ET
    $QSR
    Restaurants
    Consumer Discretionary

    $ACRE
    $AMCX
    $ARQT
    $ASIX
    Leadership Updates

    Live Leadership Updates

    View All

    Innovative Aerosystems Acquires Moog' S-TEC® Model 3100 Autopilot Product Line, Expanding Flight Control Portfolio

    Innovative Aerosystems (NASDAQ:ISSC) today announced it closed the acquisition of the Moog (NYSE:MOG) S-TEC® Model 3100 general aviation fixed wing autopilot product line, further strengthening the company's position as a leading provider of advanced avionics, flight control, and mission-critical aerospace systems for commercial, business, and military aircraft. The acquisition expands Innovative Aerosystems' integrated flight control capabilities and enhances its ability to deliver modernized, mission-ready solutions across both legacy and next-generation platforms. By incorporating the proven autopilot technology into its growing portfolio, the company will provide customers with greate

    2/23/26 8:30:00 AM ET
    $ISSC
    $MOG
    EDP Services
    Technology

    Scripps appoints VP, network sports and client partnerships to connect advertisers with sports portfolio

    CINCINNATI, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The E.W. Scripps Company (NASDAQ:SSP) has named Oliver Gray vice president, network sports and client partnerships, effective immediately, adding a proven sports sponsorship and advertising leader to fuel growth across its expanding sports and entertainment platforms. Gray will lead efforts to connect national advertisers with Scripps' platforms – including its rapidly growing sports portfolio – and will work closely across Scripps' network sales and Scripps Sports teams to develop integrated brand partnerships that deepen client relationships and drive revenue. He reports to Brian Norris, Scripps executive vice president and chief revenue o

    2/18/26 11:00:00 AM ET
    $SSP
    Broadcasting
    Industrials

    DARREN ENTWISTLE TO RETIRE JUNE 30 AFTER OVER 26 YEARS OF TRANSFORMATIONAL LEADERSHIP; TELUS CORPORATION NAMES VICTOR DODIG NEXT PRESIDENT AND CEO

    Appointment of highly accomplished and talented business leader Victor Dodig is the result of robust succession planning process by TELUS Board of Directors. Darren Entwistle recognized for leading TELUS' growth from regional telecom to a global technology leader. VANCOUVER, BC, Feb. 12, 2026 /CNW/ - The Board of Directors of TELUS Corporation (TSX:T) (NYSE:TU) today announced that, after a 26-year tenure as the company's President and Chief Executive Officer, Darren Entwistle will retire on June 30, 2026. Following a comprehensive succession planning process, the Board of Dir

    2/12/26 6:47:00 AM ET
    $TU
    Telecommunications Equipment
    Telecommunications

    $ACRE
    $AMCX
    $ARQT
    $ASIX
    Financials

    Live finance-specific insights

    View All

    Fulgent Reports Fourth Quarter and Full Year 2025 Financial Results

    Revenue of $83.3 million, growing 9% year-over-year GAAP gross profit of $32.6 million, or GAAP gross margin of 39.1%; Non-GAAP gross profit of $34.2 million, or Non-GAAP gross margin of 41.0% GAAP loss of $23.4 million, or ($0.76) per share; Non-GAAP income of $5.2 million, or $0.16 per share Ended the year with $705.5 million of cash, cash equivalents, restricted cash, and investments in marketable securities, excluding an anticipated tax refund of approximately $106.3 million Fulgent Genetics, Inc. (NASDAQ:FLGT) ("Fulgent," or the "Company"), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announce

    2/27/26 7:00:00 AM ET
    $FLGT
    Medical Specialities
    Health Care

    Natural Resource Partners L.P. Reports Fourth Quarter and Full Year 2025 Results and Announces Special Distribution

    HOUSTON, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Natural Resource Partners L.P. (NYSE:NRP) today reported fourth quarter and full year 2025 results as follows:   For the Three Months Ended  For the Year Ended (In thousands) (Unaudited) December 31, 2025 Net income $30,998  $136,367 Operating cash flow $44,765  $165,863 Free cash flow(1) $45,508  $168,748  ____________________  (1)See "Non-GAAP Financial Measures" and reconciliation tables at the end of this release. 2025 Highlights: Generated $169 million of free cash flowRetired $109 million of debt: $33 million of debt remainingPaid total distributions of $4.21 per common unit in 2025, consisting of $3.00 of regular distributions and a specia

    2/27/26 6:55:00 AM ET
    $NRP
    Coal Mining
    Energy

    InTest Reports Q4 2025 EPS of $0.10 with Revenue of $32.8 Million Amidst Improving Momentum

    Orders1 of $37.5 million driven by continued strength in Auto/EV and Life Sciences; Backlog1 up 9.4% sequentially Gross margin expanded 350 basis points sequentially to 45.4% Nearly 80% of revenue derived from non-semiconductor end markets Maintained balance sheet strength; reduced total debt by $7.6 million from December 31, 2024 InTest Corporation (NYSE:INTT), a global supplier of innovative test and process technology solutions for use in manufacturing and testing in key target markets which include semiconductor ("Semi"), Auto/EV, Defense/Aerospace, Industrial, Life Sciences, and Safety/Security, today announced financial results for the fourth quarter of 2025 ended Decembe

    2/27/26 6:15:00 AM ET
    $INTT
    Electrical Products
    Industrials

    $ACRE
    $AMCX
    $ARQT
    $ASIX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Trinseo PLC

    SC 13G - Trinseo PLC (0001519061) (Subject)

    12/17/24 5:11:10 PM ET
    $TSE
    Major Chemicals
    Industrials

    SEC Form SC 13D filed by Corebridge Financial Inc.

    SC 13D - Corebridge Financial, Inc. (0001889539) (Subject)

    12/13/24 8:00:10 AM ET
    $CRBG
    Life Insurance
    Finance

    Amendment: SEC Form SC 13D/A filed by Healthcare Realty Trust Incorporated

    SC 13D/A - Healthcare Realty Trust Inc (0001360604) (Subject)

    12/9/24 7:38:49 PM ET
    $HR
    Real Estate Investment Trusts
    Real Estate

    $ACRE
    $AMCX
    $ARQT
    $ASIX
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    What Does the Recent Purchase at GlycoMimetics Inc. on Jun 20 Indicate?

    Recently, on June 20, 2024, an insider purchase was made at GlycoMimetics Inc., grabbing the attention of investors. According to the SEC Form 4 filing, SVP Finance, CFO Hahn Brian M. bought $4,335 worth of shares (17,500 units at $0.25), boosting direct ownership by 33% to 70,643 units. Insider transactions are closely monitored by investors as they can provide insights into the company's prospects and the confidence of insiders in the business. Let's delve deeper into the recent insider purchase and analyze any potential patterns or significance in comparison to other insider transactions at GlycoMimetics Inc. In early April 2024, Goldberg Mark Alan was granted 4,584 shares, augmenting di

    6/20/24 6:20:00 PM ET
    $GLYC
    Biotechnology: Pharmaceutical Preparations
    Health Care